Current diabetes treatments work by boosting pancreatic insulin production, among other glycemic control strategies [14], decreasing intestine absorption, increasing insulin receptor sensitivity, and reducing hepatic gluconeogenesis. This evidence concerns the gene INS and diabetes mellitus.